Clinical Roundup DNA sequencing tool reveals hidden mutations that can drive cancer October 10, 2025Vol.51 No.37
Drugs & Targets FDA approves MI Cancer Seek as a CDx test for adults and pediatric patients November 08, 2024Vol.50 No.42
Drugs & Targets Genetics and sequencing company join to explore the UG 100TM sequencing platform to advance clinical test offerings in oncology and reproductive genomics October 11, 2024Vol.50 No.38
Drugs & Targets Labcorp, Ultima Genomics collaborate to advance whole genome sequencing applications and oncology testing capabilities August 02, 2024Vol.50 No.31
FreeTrials & Tribulations Engineering-level molecular diagnosis: A necessity for cancer treatment—and for a successful Moonshot July 21, 2023Vol.49 No.29By Michael P. Castro
Drugs & Targets Strata Oncology, Carbone Cancer Center integrate StrataNGS test results with Epic Genomics Module September 16, 2022Vol.48 No.33
Fate of Illumina-GRAIL $7.1B merger uncertain as (1) EU blocks it, (2) FTC administrative law judge jettisons agency’s opposition September 09, 2022Vol.48 No.32By Paul Goldberg
Drugs & Targets Thermo Fisher Scientific’s CE-IVD marked next-gen sequencing instrument available for use in clinical labs April 01, 2022Vol.48 No.13
